newsSanofi to acquire Origimm Biotechnology to develop acne vaccine2 December 2021 | By Anna Begley (European Pharmaceutical Review)Sanofi has entered into an agreement to acquire Origimm Biotechnology to add a potential first-in-class vaccine for acne to their pipeline.